317 Characterization of pharmacokinetics, pharmacodynamics, tolerability and clinical activity in phase I studies of the novel allosteric tyrosine kinase 2 (TYK2) inhibitor NDI-034858
| Autor: | Gangolli, E.A., Carreiro, S., McElwee, J.J., Dave, N., Lombardi, A., Hanna, J., Hosagrahara, V., Srivastava, B. |
|---|---|
| Zdroj: | Journal of Investigative Dermatology; August 2022, Vol. 142 Issue: 8, Number 8 Supplement 1 pS54-S54, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|